Xanodyne names CEO
Executive Summary
Xanodyne's new CEO is former Shire U.S. CEO William Nuerge. The move reunites Nuerge with Roger Griggs, who served as Xanodyne CEO until the Nov. 8 switch; Griggs will continue as chairman of Xanodyne's board. Griggs was Richwood's CEO and Nuerge was the company's COO when it merged with Shire in 1997. Nuerge was Shire U.S. CEO from 1998 until January 2004 when his position was eliminated as part of the company's consolidation of its U.S. facilities. He performed consulting work for Xanodyne in the interim before joining as CEO...